Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2019)
Pacira BioSciences' (PCRX) quarterly Other Non-Current Assets came in at $560000.0 in Q1 2019, down 26.22% year-on-year from $759000.0 in Q1 2018, and down 14.76% quarter-over-quarter from $657000.0 in Q4 2018.
Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2019) Analysis & Trends
Pacira BioSciences' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $560000.0 for Q1 2019.
- On a quarterly basis, Other Non-Current Assets fell 26.22% year-over-year to $560000.0 in Q1 2019; TTM through Mar 2019 was $560000.0, a 26.22% decrease from a year earlier, with the FY2018 full-year figure at $657000.0, down 20.36% from the prior year.
- Other Non-Current Assets fell to $560000.0 in Q1 2019 per PCRX's latest filing, from $657000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.6 million in Q3 2015 and bottomed at $406000.0 in Q4 2015.
- The 5-year median for Other Non-Current Assets is $657000.0 (2018), against an average of $945470.6.
- Across the five-year window, Other Non-Current Assets tumbled 84.31% in 2015 and surged 53.69% in 2016, its largest moves.
- Year by year, Other Non-Current Assets stood at $406000.0 in 2015, then soared by 53.69% to $624000.0 in 2016, then jumped by 32.21% to $825000.0 in 2017, then decreased by 20.36% to $657000.0 in 2018, then decreased by 14.76% to $560000.0 in 2019.
- Per Business Quant, the three latest PCRX Other Non-Current Assets figures stand at $560000.0 (Q1 2019), $657000.0 (Q4 2018), and $747000.0 (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Pacira BioSciences | 1.05 Bn | 846.97 Mn | 140.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 560,000.00 |
| Dec 31, 2018 | 657,000.00 |
| Sep 30, 2018 | 747,000.00 |
| Jun 30, 2018 | 692,000.00 |
| Mar 31, 2018 | 759,000.00 |
| Dec 31, 2017 | 825,000.00 |
| Sep 30, 2017 | 545,000.00 |
| Jun 30, 2017 | 572,000.00 |
| Mar 31, 2017 | 598,000.00 |
| Dec 31, 2016 | 624,000.00 |
| Sep 30, 2016 | 651,000.00 |
| Jun 30, 2016 | 677,000.00 |
| Mar 31, 2016 | 481,000.00 |
| Dec 31, 2015 | 406,000.00 |
| Sep 30, 2015 | 2.60 Mn |
| Jun 30, 2015 | 2.25 Mn |
| Mar 31, 2015 | 2.43 Mn |
| Dec 31, 2014 | 2.59 Mn |
| Sep 30, 2014 | 2.95 Mn |
| Jun 30, 2014 | 3.10 Mn |